An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...

Findings support model in which accelerated biological aging of mammary epithelia may underpin breast cancer susceptibility ...

Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...

PanGIA Biotech, Inc. ("PanGIA Biotech" or "Company") announced that two research abstracts have been accepted for ...

The United States Food and Drug Administration (FDA) issued guidance on its “Breakthrough Devices Program” in 2023.  The ...

Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...

Liver scarring can pave the way to cancer down the line. A new blood test in development might help doctors spot it.

Researchers have introduced groundbreaking tools—from a microfluidic platform measuring breast cell 'mechanical age' to AI-driven mammogram risk assessments—that could transform breast cancer ...